Glaukos Corp. (GKOS)
122.64
-3.70
(-2.93%)
USD |
NYSE |
Jun 10, 16:00
122.64
0.00 (0.00%)
After-Hours: 17:29
Glaukos Debt to Equity Ratio : 0.1536 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.1536 |
| December 31, 2025 | 0.1624 |
| September 30, 2025 | 0.1356 |
| June 30, 2025 | 0.1373 |
| March 31, 2025 | 0.1381 |
| December 31, 2024 | 0.138 |
| September 30, 2024 | 0.235 |
| June 30, 2024 | 0.2355 |
| March 31, 2024 | 0.8509 |
| December 31, 2023 | 0.8339 |
| September 30, 2023 | 0.8035 |
| June 30, 2023 | 0.7853 |
| March 31, 2023 | 0.7536 |
| December 31, 2022 | 0.7225 |
| September 30, 2022 | 0.6973 |
| June 30, 2022 | 0.6801 |
| March 31, 2022 | 0.6397 |
| December 31, 2021 | 0.653 |
| September 30, 2021 | 0.6362 |
| June 30, 2021 | 0.6394 |
| March 31, 2021 | 0.6147 |
| December 31, 2020 | 0.4075 |
| September 30, 2020 | 0.4031 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.3914 |
| March 31, 2020 | 0.1174 |
| December 31, 2019 | 0.1114 |
| September 30, 2019 | 0.4324 |
| June 30, 2019 | 0.4331 |
| March 31, 2019 | 0.072 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.0276 |
| June 30, 2016 | 0.0503 |
| March 31, 2016 | 0.0765 |
| December 31, 2015 | 0.1019 |
| September 30, 2015 | 0.1251 |
| June 30, 2015 | 0.2237 |
| March 31, 2015 | -0.1502 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Globus Medical, Inc. | 0.0245 |
| Insulet Corp. | 0.7279 |
| Abbott Laboratories | 0.654 |
| AngioDynamics, Inc. | 0.0657 |
| Alphatec Holdings, Inc. | 33.03 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 893.33M |
| Total Liabilities (Quarterly) | 222.40M |
| Shareholders Equity (Quarterly) | 670.93M |
| Current Ratio | 5.433 |
| Net Debt Paydown Yield | 0.01% |